💫🌟🔝🔝🔝🆕️The Lancet Commission on prostate cancer: planning for the surge in cases🌟💫

The Lancet Advanced Prostate Cancer Consensus Conference silke gillessen OncoAlert
thelancet.com/commissions/pr…
🔬 Prostate Cancer Surge by 2040*l:
🔹️Predicted to rise from 1.4M to 2.9M cases.
🔹️Driven by aging…

Most viewed in the last 7 days from JAMA Oncology:

Do prostate cancer screening pathways that incorporate MRI and targeted biopsies outperform strategies that rely solely on PSA testing and systematic biopsy?

Presented at #EAU24

ja.ma/4awLFDp

ENZA-p trial The Lancet Oncology
authors.elsevier.com/a/1iw3e5EIIgPd…
Enzalutamide + adaptive-dosed (2 or 4) 177 Lu-PSMA617 vs enza alone in mCRPC.
Biomarker guided combination therapy works!
Better response depth/duration with no added tox. ANZUP NHMRC CTC Movember Australia St Vincent's Sydney

Heavy weight in my shoulders but with everyone efforts we will drive impactful clinical outcomes in #prostatecancer using big data analytics, PIONEER+ Prostate PIONEER has now kicked-off!

Today we kicked-off an initiative that will sustain the efforts of IMI-PIONEER and that…

Summary of published (retrospective) and ongoing prospective studies of cytoreductive radical prostatectomy for oligometastatic prostate cancer

📷 credit: Nicola Fossati

UroToday.com #EAU24

#EAU24
The incredible PEACE-6 platform of European trials in mHSPC (Fizazi)

Important treatment escalation (Lu-PSMA, in poor PSA responders) and de-escalation (PSA responders 6-8 months) arms of the platform
UroToday.com

Vienna fellowship friendship dinner 🥳 #EAU24 Shahrokh F. Shariat Urologic Oncology Research MedUni Vienna Benjamin Pradere Keiichiro Mori Pawel Rajwa Tamas Fazekas MD Fahad Quhal فهد قحل MPallauf Nico Grossmann Takafumi Yanagisawa Tatsushi Kawada Marcin Ch

Our UROONCO editorial boards were busy interviewing renowned speakers at #EAU24 on hot topics in GU cancers which are being presented at EAU24. Stay tuned!

#prostatecancer #bladdercancer #kidneycancer

Benjamin Pradere Giancarlo Marra Pawel Rajwa

MRI scans may help reduce unnecessary biopsies & diagnose more aggressive cancers.
✅ A meta-analysis of over 80,000 men found MRI led to:
⭕️Fewer biopsies overall (down to 28%)
⭕️Less detection of slow-growing cancers
⭕️Similar detection of high-risk cancers
👉This could mean…

Really interesting new data on PCa screening #EAU24 Re-Imagine trial Caroline Moore shows many PCa in men < 3 ng/mL but Göteborg-2 trial shows possible overdiagnosis in 1.8-3 ng/mL European Urology. PRAISE-U and Organized Prostate Testing programs will provide more data. Praise_U

“Great surgeons are less remembered by their operations but more for their trainees”

Great insights in #EAU24 plenary by Prof Francesco Montorsi

Why rush radiotherapy after prostate surgery?
☢️RADICALS-RT trial shows waiting for PSA rise before radiotherapy could be the smarter move – fewer side effects without compromising cancer control. A potential game-changer for post-surgery treatment. #ProstateCancer
Matt Sydes…

The integration of magnetic resonance imaging in #prostatecancer screening offers a promising shift from reliance solely on PSA testing 💉A meta-analysis of 80,114 men across 12 studies reveals that MRI-based screening 📉 unnecessary biopsies and detects clinically significant…

Key paper highlighting value of MRI based screening strategies for prostate cancer. Tipping the balance the right way perhaps? For more live talks on MRI in PCa diagnosis come to the dedicated plenary session at #EAU24 European Association of Urology (EAU) European Society of Residents in Urology Details here: x.com/primemri/statu…

Check out our recent paper on #MRI in #prostatecancer screening!

Key findings in the comments 👇🏼👇🏼

Shahrokh F. Shariat Pawel Rajwa Nyirády Dr. Péter Michael Leapman Ivo Schoots Giorgio Gandaglia Veeru Kasi Ploussard Guillaume Roderick van den Bergh Juan Gómez Rivas Tibor Szarvas JAMA Oncology

jamanetwork.com/journals/jamao…

Read our recent paper on prostate MRI and PCa screening!

Our new study ‼️ Published in JAMA Oncology ‼️

Magnetic Resonance Imaging in Prostate Cancer Screening

Congrats to Tamas Fazekas MD ! Rising rockstar! 🇭🇺

Shahrokh F. Shariat Michael Leapman Roderick van den Bergh Ivo Schoots Giorgio Gandaglia Juan Gómez Rivas Veeru Kasi Ploussard Guillaume Nyirády Dr. Péter
jamanetwork.com/journals/jamao…

New systematic review on metastatic #prostatecancer treatment reveals 15 predictive models, but most need further validation before clinical use.

Only one study showed low bias and applicability risk. More research needed for better treatment decisions

Prostate PIONEER…

Meet us at the #EAU24 joint session of the European Association of Urology (EAU) European Association of Urology (EAU) and the Advanced Prostate Cancer Consensus (APCCC) this April 7th🗓️

Dive into an intensive study of advanced prostate cancer care.

Silke Gillessen and Bertrand Tombal will be steering this…

Worth reading/considering from Adam Kibel and BWH/MGH group. Reminder that temperance and 'less is more' often leads to better patient care (not common traits in our health system).

MRI, Clinical, and Biopsy Findings in Suspected Prostate Cancer jamanetwork.com/journals/jaman…